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The significance of the glucocorticoid
receptor (GR) in stress response regula-
tion and mood disorders has been demon-
strated by many studies in animal and
humanmodels (Anacker et al., 2011a). The
paper by Griffiths’ and colleagues adds to
this evidence, by investigating GR function
and its role in stress response regulation
and antidepressant action in an exciting
new zebrafish model.
The main finding of this study is that
mutant zebrafish larvae with impaired GR
transactivation, due to a single nucleotide
substitution in a region essential for DNA
binding (grs357 mutants), exhibit behav-
ioral abnormalities and neuroendocrine
dysfunction. Specifically, grs357 mutants
show elevated startle responses, a sur-
rogate measure of anxiety-like behav-
ior in fish, as well as increased cortisol
levels and impaired HPA axis feedback
control, demonstrated by reduced sup-
pression of pituitary pomc upon treat-
ment with the synthetic glucocorticoid,
betamethasone. The authors also test
whether the selective serotonin reuptake
inhibitor (SSRI) antidepressant, fluoxe-
tine, is able to reverse the neuroen-
docrine and behavioral phenotype of
grs357 mutants. Their findings suggest
that fluoxetine does not reverse neu-
roendocrine abnormalities resulting from
impaired GR transactivation, while it still
effectively counteracts anxiety-like behav-
ior. These findings confirm the crucial
role of the GR in neuroendocrine reg-
ulation and behavioral stress responses,
and are in line with the authors’ previous
work, in which they have identified stress
axis abnormalities and increased freezing
behavior upon exposure to a novel envi-
ronment in the same mutant fish (Ziv
et al., 2012). Their new findings thus con-
solidate the use of the zebrafish model
to investigate GR-dependent regulation of
the stress response.
The data suggest that some of the
behavioral effects of fluoxetine on revers-
ing startle response abnormalities may
be independent of GR transactivation
in fish. However, it is important to
note that many GR-mediated effects are
indeed independent of direct GR binding to
the DNA, particularly the glucocorticoid-
mediated regulation of pomc expression
(Tuckermann et al., 1999; Bilodeau et al.,
2006). It thus remains to be elucidated
whether GR protein-protein interactions,
such as transrepression of the transcrip-
tion factors NFkB, AP-1, or cyclic AMP
response element binding protein (CREB),
may indeed account for some of the SSRI
effects on anxiety-like behavior in this
study. Moreover, an increasing body of
work suggests that a membrane-bound
GR may mediate some of the rapid, non-
genomic effects of glucocorticoids, partic-
ularly glucocorticoid-induced changes in
neuronal excitability and memory consol-
idation (for comprehensive reviews, please
see: Haller et al., 2008 and Groeneweg
et al., 2012). While previous studies have
shown a crucial role for genomic GR
effects in antidepressant action (Anacker
et al., 2011b), the involvement of the
membrane-bound form of the GR in the
mechanism of action of antidepressants
remains elusive and may possibly account
for some of the behavioral changes upon
antidepressant treatment in grs357 mutant
fish, in which only GR transactivation is
abolished. As the authors suggest, the role
of serotonergic signaling on the neuroen-
docrine system, behavior, and the regu-
lation of GR function is likely to be of
great importance for the effects of SSRI
antidepressants (Laplante et al., 2002).
At the same time, potential serotonin-
independent molecular mechanisms of
antidepressant action, such as liberation
of G-proteins from membrane associated
lipid rafts, have been suggested (Donati
and Rasenick, 2005), and may represent
possible alternative pathways involved in
stress response regulation and GR activa-
tion, which warrant further investigation.
Of course, when modeling psychiatric
disorders in fish, it needs to be carefully
considered that the behavioral repertoire,
the neural networks and the psycholog-
ical responses to stress in teleosts are
largely different from respective responses
in the mammalian brain. Behavioral stud-
ies in higher animals, such as rodents
and primates, as well as cellular and
molecular studies in human tissues, will
therefore indeed remain indispensable
for our understanding of stress-induced
brain abnormalities, depression patho-
physiology, and antidepressant treatment
response. To this end, it will be interest-
ing for future investigations to examine
if other well established neurobiological
correlates of depression, such as alter-
ations in neuronal gene expression or
adult neurogenesis, can also be mod-
eled in comparable regions of the fish
brain (Kizil et al., 2012). In addition,
evolutionary differences in corticosteroid
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receptor function have been demonstrated
and need to be considered when investi-
gating GR function across different phy-
logenetic taxa (Bury and Sturm, 2007).
Nevertheless, the zebrafish is a useful
model to investigate principle mecha-
nisms underlying stress response regula-
tion, and it offers a unique possibility for
high-throughput drug screening in vivo,
facilitating the discovery of new targets
that alter neuroendocrine responses and
proxy measures of stress-induced behav-
ioral abnormalities.
In order to identify new treatment tar-
gets and to elucidate the sophisticated
heterogeneous mechanisms underlying
depression pathogenesis, a cross-species
investigation into the several layers of the
complex nature of stress-induced biolog-
ical abnormalities will be essential to our
success. The paper by Griffiths’ and col-
leagues, together with previous work on
GR function in zebrafish (Ziv et al., 2012),
is a great example for such an approach,
and offers a novel high-throughput plat-
form in live fish to investigate drug
responses and GR function in an in vivo
system.
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